Skip to main content
Table of Contents
Print

Are There Gender Differences in Cannabis Effectiveness for EDS? 

Author: Dr. Clarissa Morton, PharmD

As more individuals with Ehlers-Danlos Syndrome (EDS) turn to cannabis for symptom relief, growing attention is being paid to the gender, cannabis, and EDS relationship. Researchers and patients alike are asking whether gender plays a role in how effective cannabis is for managing EDS symptoms. Gender differences in pain perception, hormone levels, and cannabis absorption may all play a role in how cannabis affects EDS patients differently. 

How Gender Cannabis EDS May Differ Between Men and Women 

  • Hormonal Factors and Response to Cannabis: 
    One key consideration in the gender, cannabis, and EDS relationship is the impact of hormonal factors. For women, fluctuating hormone levels, particularly estrogen and progesterone, can influence the body’s response to cannabis. Research shows that women may experience stronger effects from cannabis during certain phases of the menstrual cycle. This hormonal fluctuation can affect how cannabis impacts pain relief, inflammation, and overall symptom management in EDS patients. 
  • Differences in CBD Absorption: 
    Studies suggest that men and women metabolise cannabinoids differently. Women often have a higher concentration of fat cells, which may result in more efficient CBD absorption and longer-lasting effects. This could influence how cannabis impacts individuals based on their body composition and biological sex. 
  • Effectiveness of Cannabis for Effectiveness in EDS Patients: 
    While cannabis can be beneficial for both men and women with EDS, some studies suggest that women may respond more favourably to CBD for managing chronic pain and inflammation. This could be due to differences in the endocannabinoid system, which regulates pain and inflammation. As a result, effectiveness may vary, with women experiencing more consistent benefits from cannabis use compared to men. 

Understanding the Role of Gender Cannabis EDS in Treatment Plans 

Recognising the potential gender, cannabis, and EDS relationship differences can help tailor treatment strategies for better outcomes. By considering factors like hormonal changes and CBD absorption, healthcare providers can better guide patients in selecting the right cannabis product and dosage for their needs. 

If you’re curious about how cannabis may affect your treatment plan, it’s important to consult a healthcare provider to discuss your specific needs and medical history.   

Visit providers like LeafEase for personalised consultations to optimise your cannabis use for EDS. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Ehlers-Danlos Syndrome.

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories